Provided by Tiger Trade Technology Pte. Ltd.

Mistras Group Inc

18.76
+0.27001.46%
Post-market: 19.130.3700+1.97%19:30 EDT
Volume:197.39K
Turnover:3.68M
Market Cap:596.88M
PE:22.81
High:18.96
Open:18.40
Low:18.17
Close:18.49
52wk High:20.20
52wk Low:9.35
Shares:31.82M
Float Shares:9.25M
Volume Ratio:1.08
T/O Rate:2.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8225
EPS(LYR):0.5300
ROE:11.78%
ROA:6.35%
PB:2.49
PE(LYR):35.40

Loading ...

MISTRAS Group schedules quarterly results conference call

Reuters
·
Apr 22

Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 Trial

GlobeNewswire
·
Apr 21

Cabaletta Bio: RESET-MG Data and Differentiated Autoimmune Strategy Underpin Buy Rating and Upside Potential

TIPRANKS
·
Apr 21

MISTRAS Group Receives Frost & Sullivan’s 2026 Global NDT Field Inspection Services Company of the Year Recognition

GlobeNewswire
·
Apr 20

argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP

GlobeNewswire
·
Apr 18

Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026

GlobeNewswire
·
Apr 09

MISTRAS Group announces annual shareholder meeting webcast

Reuters
·
Apr 08

MG Home Co Raises FY Net View to Y1.07B

Dow Jones
·
Apr 01

Press Release: Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update

Dow Jones
·
Mar 09

argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline

GlobeNewswire
·
Mar 06

Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026

GlobeNewswire
·
Mar 06

MISTRAS Group Corrects Q4 2025 Non-GAAP Diluted EPS to $0.25

Reuters
·
Mar 06

MISTRAS Group Issues Clarification Regarding Diluted EPS Excluding Special Items (Non-GAAP) Referenced During Q4 2025 Earnings Call

GlobeNewswire
·
Mar 06

Mistras Group Q4 Non-GAAP Earnings, Revenue Rise

MT Newswires Live
·
Mar 05

MISTRAS Q4 revenue beats estimates

Reuters
·
Mar 05

BRIEF-MISTRAS Q4 Revenue USD 181.5 Million Vs. IBES Estimate USD 176.5 Million

Reuters
·
Mar 05

Mistras Q4 Gross Profit USD 51.5 Million

THOMSON REUTERS
·
Mar 05

Mistras Q4 Gross Margin 28.4%

THOMSON REUTERS
·
Mar 05

Mistras Q4 Revenue USD 181.5 Million VS. Ibes Estimate USD 176.5 Million

THOMSON REUTERS
·
Mar 05

MISTRAS Announces Fourth Quarter and Full Year 2025 Results

GlobeNewswire
·
Mar 05